How Medicenna is Developing "Superkines" as Novel Immunotherapies

from Rx for Biotech · host Podcast Host Chris Leidli

In this podcast episode, our guest is Dr. Fahar Merchant, President and CEO of Medicenna Therapeutics. Medicenna is a clinical stage immunotherapy company that engineers novel, powerful and proprietary interleukins leveraging their Superkine Platform to modulate, fine-tune or amplify the immune system to tackle the most challenging diseases, including a broad range of cancers.

Episode metadata supplied by the publisher feed · Published Aug 31, 2023

Embed this episode

Attribution link and audio player

NOW PLAYING

How Medicenna is Developing "Superkines" as Novel Immunotherapies

0:00 29:45

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

Wild WinsDay Wild WinsDay Pump the hump with WILD WINSday 🐪💪: Your 3-minute weekly video boost for leadership, sales, marketing, and business breakthroughs to WIN the day!

Frequently Asked Questions

How long is this episode of Rx for Biotech?

This episode is 29 minutes long.

When was this Rx for Biotech episode published?

This episode was published on August 31, 2023.

Can I download this Rx for Biotech episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!